CN103223155B - Medicament for treating postpartum hemorrhage - Google Patents
Medicament for treating postpartum hemorrhage Download PDFInfo
- Publication number
- CN103223155B CN103223155B CN201310184833.3A CN201310184833A CN103223155B CN 103223155 B CN103223155 B CN 103223155B CN 201310184833 A CN201310184833 A CN 201310184833A CN 103223155 B CN103223155 B CN 103223155B
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- radix
- herba
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating postpartum hemorrhage, which is prepared from the following components in certain parts by weight: figwort, cornel, Acorus gramineus, ephedra, clove, saururus chinensis, red tangerine peel, rhizoma sparganii, rhubarb, equisetum, eupatorium, rhizoma anemarrhenae, tuckahoe, dried orange peel, moutan bark, eucommia, kudzu root, heracleum hemsleyanum michaux, Rhizoma Zedoariae, selfheal, Alpinia katsumadai, radix curcumae, myrrh, Curculigo orchioides, folium artemisiae argyi, flower of silktree, rhiaoma iridis tectori, acanthopanax bark, rangooncreeper fruit, emblic leafflower fruit, Fructus Forsythiae, immature bitter orange, rhizoma alismatis, gromwell, Ligotidis Herba, Phytolacca acinosa, rose, magnolia flower, Herba Polygalae Japonicae, radix sileris, dried ginger, seville orange flower, murraya jasminorage, aspongopus, rhizoma pleionis, morinda root, pomegranate rind, morning glory seed, gerba pyrolae and marsdeniae tenacissimae caulis. The medicament provided by the invention has the advantages of accessible raw materials and exact curative effect; and tests prove that the medicament is high in effective rate and low in cost.
Description
Technical field
The present invention relates to department of obstetrics and gynecology field, relate in particular to a kind of medicine for the treatment of postpartum hemorrhage.
Background technology
Postpartum hemorrhage, as one of the most serious term complication, is also the first reason of the current pregnant and lying-in women's of causing clinical death.At present clinically generally adopt oxytocin prevent and control, though effect is better, because oxytocin must drug administration by injection, and individual sensitivity differs greatly, and therefore in the time that actual therapeutic is applied, has inconvenience.
Summary of the invention
The object of this invention is to provide a kind of medicine for the treatment of postpartum hemorrhage.
In order to realize object of the present invention, the invention provides a kind of medicine for the treatment of postpartum hemorrhage, it is to be made up of the material of following weight parts: 10 parts of Radix Scrophulariaes, 10 parts of Fructus Corni, 20 parts of Rhizoma Acori Graminei, 20 parts, Herba Ephedrae, 8 parts of Flos Caryophyllis, 25 parts of Rhizoma Saururi (Herba Saururi)s, 13 parts of Exocarpium Citri Rubrums, 30 parts of Rhizoma Sparganii, 5 parts of Radix Et Rhizoma Rhei, 25 parts of Herba Equiseties Hiemalis, 15 parts of Herba Eupatoriis, 25 parts of the Rhizoma Anemarrhenaes, 40 parts, Poria, 20 parts of Pericarpium Citri Reticulataes, 10 parts of Cortex Moutans, 15 parts of the Cortexs Eucommiae, 20 parts of Radix Puerariaes, 10 parts of Radix Angelicae Pubescentiss, 15 parts of Rhizoma Curcumae, 30 parts of Spica Prunellaes, 15 parts of Semen Alpiniae Katsumadai, 30 parts of Radix Curcumaes, 20 parts of Myrrhas, 15 parts of Rhizoma Curculiginises, 35 parts of Folium Artemisiae Argyis, 25 parts of Flos Albiziaes, 25 parts of Rhizoma Belamcandaes, 26 parts of Cortex Acanthopanciss, 15 parts of Fructus Quisqualis, 25 parts of Fructus Phyllanthis, 30 parts of Fructus Forsythiaes, 15 parts of Fructus Aurantii Immaturuss, 30 parts of Rhizoma Alismatis, 10 parts of Radix Arnebiae (Radix Lithospermi)s, 5 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 10 parts of Radix Phytolaccaes, 10 parts of Flos Rosae Rugosaes, 20 parts of Flos Magnoliaes, 10 parts of Herba Polygalae Japonicae, 25 parts of Radix Saposhnikoviaes, 25 parts of Rhizoma Zingiberiss, 10 parts of CitrusaurantiumL.Var.amara Engl.s, 45 parts of Folium Et Cacumen Murrayae, 60 parts of Aspongopuss, 50 parts of Pseudobulbus Cremastrae Seu Pleioness, 50 parts of Radix Morindae Officinaliss, 70 parts of Pericarpium Granatis, 40 parts of Semen Pharbitidiss, 50 parts of 35 parts of Herba Pyrolaes and Caulis Marsdeniae Tenacissimaes.
Preferably, medicine of the present invention can be made tablet, dispersible tablet, capsule or powder.
Raw material of the present invention is easy to get, determined curative effect, and high through evidence effective percentage, cost is low.
Detailed description of the invention
Below the invention will be further described for the description by detailed description of the invention, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various amendments or improvement, but only otherwise depart from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 powder of the present invention
Get 10 grams of Radix Scrophulariaes, 10 grams of Fructus Corni, 20 grams of Rhizoma Acori Graminei, 20 grams, Herba Ephedrae, 8 grams of Flos Caryophyllis, 25 grams of Rhizoma Saururi (Herba Saururi)s, 13 grams of Exocarpium Citri Rubrums, 30 grams of Rhizoma Sparganii, 5 grams of Radix Et Rhizoma Rhei, 25 grams of Herba Equiseties Hiemalis, 15 grams of Herba Eupatoriis, 25 grams of the Rhizoma Anemarrhenaes, 40 grams, Poria, 20 grams of Pericarpium Citri Reticulataes, 10 grams of Cortex Moutans, 15 grams of the Cortexs Eucommiae, 20 grams of Radix Puerariaes, 10 grams of Radix Angelicae Pubescentiss, 15 grams of Rhizoma Curcumae, 30 grams of Spica Prunellaes, 15 grams of Semen Alpiniae Katsumadai, 30 grams of Radix Curcumaes, 20 grams of Myrrhas, 15 grams of Rhizoma Curculiginises, 35 grams of Folium Artemisiae Argyis, 25 grams of Flos Albiziaes, 25 grams of Rhizoma Belamcandaes, 26 grams of Cortex Acanthopanciss, 15 grams of Fructus Quisqualis, 25 grams of Fructus Phyllanthis, 30 grams of Fructus Forsythiaes, 15 grams of Fructus Aurantii Immaturuss, 30 grams of Rhizoma Alismatis, 10 grams of Radix Arnebiae (Radix Lithospermi)s, 5 grams of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 10 grams of Radix Phytolaccaes, 10 grams of Flos Rosae Rugosaes, 20 grams of Flos Magnoliaes, 10 grams of Herba Polygalae Japonicae, 25 grams of Radix Saposhnikoviaes, 25 grams of Rhizoma Zingiberiss, 10 grams of CitrusaurantiumL.Var.amara Engl.s, 45 grams of Folium Et Cacumen Murrayae, 60 grams of Aspongopuss, 50 grams of Pseudobulbus Cremastrae Seu Pleioness, 50 grams of Radix Morindae Officinaliss, 70 grams of Pericarpium Granatis, 40 grams of Semen Pharbitidiss, 50 grams of 35 grams of Herba Pyrolaes and Caulis Marsdeniae Tenacissimaes, pulverize, and crosses 100 mesh sieves, then adds 250 grams of sucrose, mixes, and packs in 100 bags and get final product.
Experimental example
Select through drug induced abortion and meet following condition person and include investigation in: menolipsis≤49 day, age≤40 year old, healthy, without intrauterine device, before medicine stream routine blood test, liver function detect normal, Urine HCG positive, it is in utero pregnant that B ultrasonic confirms, can follow up a case by regular visits to.Choose patient's 60 examples that meet above-mentioned condition, minimum 24 years old of age, maximum 36 years old, 27.3 years old mean age.
Treat with the powder making in embodiment 1, wherein one day 2 times, each one bag 5 days is 1 course for the treatment of.Inactive other drug during treatment.
Criterion of therapeutical effect
Recovery from illness: clinical symptoms, sign all disappear, lab testing urine pregnancy tests feminine gender, ultrasound diagnosis belongs to normal uterus adnexa ultrasonogram.Take a turn for the better: clinical symptoms, sign disappear substantially, but do not do urine pregnancy tests and ultrasound diagnosis.Do not heal: clinical symptoms, sign are not improved.
Therapeutic outcome
Described 60 routine patients clinical symptoms, sign after treatment all disappear, lab testing urine pregnancy tests feminine gender, and ultrasound diagnosis belongs to normal uterus adnexa ultrasonogram, all meets the standard of recovery from illness.And do not observe obvious untoward reaction.
After this in 1 month, all patient is followed up a case by regular visits to weekly, found that recurrence does not all appear in all patients.
Claims (1)
1. treat a medicine for postpartum hemorrhage, it is characterized in that it is to be made up of the material of following weight parts: 10 parts of Radix Scrophulariaes, 10 parts of Fructus Corni, 20 parts of Rhizoma Acori Graminei, 20 parts, Herba Ephedrae, 8 parts of Flos Caryophyllis, 25 parts of Rhizoma Saururi (Herba Saururi)s, 13 parts of Exocarpium Citri Rubrums, 30 parts of Rhizoma Sparganii, 5 parts of Radix Et Rhizoma Rhei, 25 parts of Herba Equiseties Hiemalis, 15 parts of Herba Eupatoriis, 25 parts of the Rhizoma Anemarrhenaes, 40 parts, Poria, 20 parts of Pericarpium Citri Reticulataes, 10 parts of Cortex Moutans, 15 parts of the Cortexs Eucommiae, 20 parts of Radix Puerariaes, 10 parts of Radix Angelicae Pubescentiss, 15 parts of Rhizoma Curcumae, 30 parts of Spica Prunellaes, 15 parts of Semen Alpiniae Katsumadai, 30 parts of Radix Curcumaes, 20 parts of Myrrhas, 15 parts of Rhizoma Curculiginises, 35 parts of Folium Artemisiae Argyis, 25 parts of Flos Albiziaes, 25 parts of Rhizoma Belamcandaes, 26 parts of Cortex Acanthopanciss, 15 parts of Fructus Quisqualis, 25 parts of Fructus Phyllanthis, 30 parts of Fructus Forsythiaes, 15 parts of Fructus Aurantii Immaturuss, 30 parts of Rhizoma Alismatis, 10 parts of Radix Arnebiae (Radix Lithospermi)s, 5 parts of Lagotis clarkei Hook. F (Lagotis brevituba Maxim.), 10 parts of Radix Phytolaccaes, 10 parts of Flos Rosae Rugosaes, 20 parts of Flos Magnoliaes, 10 parts of Herba Polygalae Japonicae, 25 parts of Radix Saposhnikoviaes, 25 parts of Rhizoma Zingiberiss, 10 parts of CitrusaurantiumL.Var.amara Engl.s, 45 parts of Folium Et Cacumen Murrayae, 60 parts of Aspongopuss, 50 parts of Pseudobulbus Cremastrae Seu Pleioness, 50 parts of Radix Morindae Officinaliss, 70 parts of Pericarpium Granatis, 40 parts of Semen Pharbitidiss, 50 parts of 35 parts of Herba Pyrolaes and Caulis Marsdeniae Tenacissimaes.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310184833.3A CN103223155B (en) | 2013-05-20 | 2013-05-20 | Medicament for treating postpartum hemorrhage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310184833.3A CN103223155B (en) | 2013-05-20 | 2013-05-20 | Medicament for treating postpartum hemorrhage |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103223155A CN103223155A (en) | 2013-07-31 |
CN103223155B true CN103223155B (en) | 2014-07-09 |
Family
ID=48833951
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310184833.3A Expired - Fee Related CN103223155B (en) | 2013-05-20 | 2013-05-20 | Medicament for treating postpartum hemorrhage |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103223155B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103239700A (en) * | 2013-05-20 | 2013-08-14 | 黄慧 | Medicament for treating rheumatism |
CN103251918A (en) * | 2013-06-03 | 2013-08-21 | 袁梅 | Medicine for treating gastrointestinal tract diseases |
CN103251919A (en) * | 2013-06-03 | 2013-08-21 | 史秀华 | Medicine for treating upper respiratory tract infections |
CN103285355B (en) * | 2013-06-14 | 2015-05-13 | 孟凡美 | Medicine for treating calculi in urinary system |
CN104771572B (en) * | 2015-03-30 | 2018-05-18 | 邵田 | Chinese medicine preparation for postpartum hemostasis and preparation method thereof |
CN104758619A (en) * | 2015-04-20 | 2015-07-08 | 任红霞 | Medicine for treating postpartum hemorrhage |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100998634A (en) * | 2006-01-13 | 2007-07-18 | 李晓华 | Traditional Chinese medicine composition for preventing postpartum weakness type cold and its preparing method |
CN101032618A (en) * | 2007-04-09 | 2007-09-12 | 武传中 | Chinese traditional medicine for curing late puerperal hemorrhage |
-
2013
- 2013-05-20 CN CN201310184833.3A patent/CN103223155B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100998634A (en) * | 2006-01-13 | 2007-07-18 | 李晓华 | Traditional Chinese medicine composition for preventing postpartum weakness type cold and its preparing method |
CN101032618A (en) * | 2007-04-09 | 2007-09-12 | 武传中 | Chinese traditional medicine for curing late puerperal hemorrhage |
Non-Patent Citations (2)
Title |
---|
加味生化汤在产后出血中的应用;李晓洁;《吉林医学》;20111031;第32卷(第28期);5950 * |
李晓洁.加味生化汤在产后出血中的应用.《吉林医学》.2011,第32卷(第28期),5950. |
Also Published As
Publication number | Publication date |
---|---|
CN103223155A (en) | 2013-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103223155B (en) | Medicament for treating postpartum hemorrhage | |
CN101642529B (en) | Preparation capable of treating diabetes | |
CN101780160B (en) | Traditional Chinese medicine preparation for treating gynecological disease and preparation method thereof | |
CN105560827B (en) | A kind of ointment and preparation method thereof for perimenopausal syndrome conditioning | |
CN106362104A (en) | Pharmaceutical composition for treating polycystic ovary syndrome in adolescence | |
CN101214315B (en) | Medicament for preventing and treating gynaecologic hemorrhage and preparation thereof | |
CN102526566A (en) | Chinese medicine preparation for treating hysteromyoma and ovarian cyst and preparation method | |
CN105617151A (en) | Powder boiling type traditional Chinese medicine antibacterial and anti-inflammatory agent, preparation method and applications thereof | |
CN103263650B (en) | Chinese medicament for conditioning female menstruation | |
CN102008688B (en) | Medicament for treating periodic psychosis | |
CN103251918A (en) | Medicine for treating gastrointestinal tract diseases | |
CN105031597A (en) | Traditional Chinese medicine drug used for treating infertility and habitual abortion | |
CN103349760A (en) | Medicine for treating colporrhagia after abortion | |
CN103495079B (en) | Chinese herbal compound composition with male infertility therapy effect and preparation method and application of Chinese herbal compound composition | |
CN103751747B (en) | A kind of Chinese medicine of medicine colporrhagia due to abortion disease | |
CN106309636B (en) | Pharmaceutical composition for uterine bleeding | |
CN103989737A (en) | Preparation method for pharmaceutical composition for treating chronic pelvic inflammation | |
CN103330929B (en) | Medicine for curing female infertility and preparation method thereof | |
CN104958692A (en) | Medicinal composition for treating hyperprolactinaemic infertility, and application thereof | |
CN114699474A (en) | Traditional Chinese medicine composition for treating ovarian reserve function reduction and application thereof | |
CN105250952B (en) | A kind of Chinese medicine composition for treating uterus adenomyosis | |
CN102552808B (en) | Medicament for treating vaginal bleeding after abortion | |
CN116135221A (en) | Wuzi Yichong prescription and preparation and application thereof | |
CN100396318C (en) | Drug for treating endometriosis | |
CN103285232B (en) | Traditional Chinese medicine for preventing habitual abortion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140709 Termination date: 20150520 |
|
EXPY | Termination of patent right or utility model |